(unless otherwise specified, the monetary unit is RMB) 1. Basic information of the company
1.1 company profile
Chengda Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”, “the company” and “Chengda pharmaceutical”) was restructured from Zhejiang Jiashan Chengda Pharmaceutical Chemical Co., Ltd. (hereinafter referred to as “Chengda Co., Ltd.” and “Chengda Co., Ltd”). On September 30, 2009, it obtained the Zhejiang business foreign investment letter [2009] from the Department of Commerce of Zhejiang Province According to document No. 183, it is agreed that the company will be changed into a foreign-invested joint stock company and renamed “Chengda Pharmaceutical Co., Ltd.”. On November 16, 2009, the company renewed the approval certificate (s.w.z.f.z. [2006] 00680); On December 9, 2009, it obtained the business license of enterprise legal person with registration number of 330400400005966 issued by Zhejiang Administration for Industry and commerce. The business license with unified social credit code of 913300007044199935 was renewed on February 19, 2016. The legal representative of the company is Ge Jianli, and the registered address is No. 36, Huanghe Road, Huimin street, Jiashan County, Zhejiang Province.
As of June 30, 2021, the registered capital of the company is RMB 72522105.00 and the share capital is RMB 72522105.00. The above capital contribution was verified by Zhonghua Certified Public Accountants (special general partnership) and confirmed by issuing the capital verification report no. 7763 (2019) on December 20, 2019. The actual capital contributions of all shareholders are shown in the table below:
Number of shares held by shareholders (10000 shares) proportion of share capital / proportion of registered capital
Ge Jianli 2626.9636 22%26,269,600.0036. 22% Shenzhen Qianhai Shengtai investment enterprise (limited partnership) 1550.0021.37% 15500000.0021.37% Huang Honglin 1220.5016.83% 12205000.0016.83% Jiashan Huida investment partnership (limited partnership) 380.005.24% 3800000.005.24% Jiaxing maierte equity investment partnership (limited partnership) 273.68423.77% 2736842.003.77% Hangzhou Chenghe Shanda investment partnership (limited partnership) 218.003.01% 218000.003.01% Shanghai fujiurong enterprise management center (limited partnership) 210.52632.90% 2105263.002.90% Jiashan Huicheng equity investment partnership (limited partnership) 208.042.87% 2080400.002.87% Shenzhen JiuHeng Investment Consulting Co., Ltd. 200.002.76% 2000000.002.76% Wang Zhe 200.002.76% 2000000.002.76% Jiashan Hecheng equity investment partnership (limited partnership) 164.502.27% 164500.002.27% total 7252.2105100.00% 72522105.00100.00% business scope of the company: production of API (operated by the drug production license of the people’s Republic of China), production and sales of food additives (operated by the national industrial product production license), feed additives (operated by the feed additive production license) Operation), pharmaceutical intermediate chemical raw materials and chemical products (excluding precursor drugs, in which the production and storage of dangerous chemicals are limited, and the operation shall be carried out by virtue of the approval certificate for the production and storage of dangerous chemicals in Jiaxing), technical R & D and transfer of technical achievements of API and pharmaceutical intermediates.
(unless otherwise specified, the monetary unit is RMB) 1 basic information of the company (Continued)
1.2 historical evolution
1.2. 1. Equity change of the limited company
(1) In March 1999, Chengda Co., Ltd. was established
On March 25, 1999, Ge Jianli, Huang Honglin and Zheng tucai jointly funded the establishment of Zhejiang Jiashan Chengda Pharmaceutical Chemical Co., Ltd. in currency. The company was registered for industrial and commercial establishment according to law and obtained the business license of enterprise legal person with Registration No. 3304211103391 issued by the Administration for Industry and Commerce of Jiashan County, Zhejiang Province. The legal representative of the company is Ge Jianli. At the time of establishment, the registered capital of the company was 500000 yuan, and its business scope is the production and sales of amikacin raw materials.
On March 22, 1999, Chengda Co., Ltd. paid in full the registered capital of 500000.00 yuan. Jiashan audit firm verified the capital contribution and issued the capital verification report (s.s.y. [1999] No. 072) for confirmation.
When Chengda Co., Ltd. was established, the capital contributions of each shareholder were as follows:
Capital contribution amount (yuan) and proportion of capital contribution
Ge Jianli 250000.0050.00 00% Huang Honglin 150000.0030.00 00% Zheng tucai 100000.0020.00 00% total 500000.00100.00 00% (2) in June 1999, the first equity transfer of Chengda Co., Ltd
On June 5, 1999, Chengda Co., Ltd. held a shareholders’ meeting and made a resolution to agree that Zheng tucai transferred RMB 50000.00 to ge Jianli and Huang Honglin respectively according to the original capital contribution price, and handled the industrial and commercial change registration according to law.
After the equity transfer, the equity structure of Chengda Co., Ltd. is as follows:
Capital contribution amount (yuan) and proportion of capital contribution
Ge Jianli 300000.0060 00% Huang Honglin 200000.0040 00% total 500000.00100.00 00% (3) in July 2000, Chengda Co., Ltd. increased its capital for the first time (absorbed and merged Chengcheng chemical)
On March 2, 2000, Chengda Co., Ltd. and Chengcheng chemical passed the resolution of the shareholders’ meeting respectively, agreeing that Chengda Co., Ltd. shall absorb and merge Chengcheng chemical, and Chengda Co., Ltd. shall inherit all the debts of Chengcheng chemical; On the same day, Chengda Co., Ltd. and Chengcheng chemical signed the enterprise merger agreement, which agreed that all assets and creditor’s rights of Chengcheng chemical belong to Chengda Co., Ltd. and all debts shall be repaid by Chengda Co., Ltd; The registered capital of Chengda Co., Ltd. surviving after the merger is the sum of the registered capital of the two companies before the merger of RMB 1000000.00, which is cancelled by Chengcheng chemical.
On July 6, 2000, Sizhou United Certified Public Accountants verified the merger and issued the capital verification report (sihyy [2000] No. 168) on July 6, 2000 for confirmation.
On July 18, 2000, Chengda Co., Ltd. carried out the industrial and commercial change registration according to law and obtained the business license with the registration number of 3304211103391 issued by the Administration for Industry and Commerce of Jiashan County, Zhejiang Province.
(unless otherwise specified, the monetary unit is RMB) 1 basic information of the company (Continued)
1.2 historical evolution (Continued)
1.2. 1. Equity changes of the limited company (Continued)
(3) In July 2000, Chengda Co., Ltd. increased its capital for the first time (absorbed and merged Chengcheng chemical) (Continued)
After the completion of this absorption and merger, the equity structure of Chengda Co., Ltd. is as follows:
Capital contribution amount (yuan) and proportion of capital contribution
Ge Jianli 600000.0060 00% Huang Honglin 400000.0040 00% total 1000000.00100.00 00% (4) in June 2006, Chengda Co., Ltd. transferred its equity for the second time and changed it into a foreign-invested enterprise
On March 28, 2006, Chengda Co., Ltd. held a shareholders’ meeting and made a resolution to agree Ge Jianli and Huang Honglin to transfer their capital contribution of 450000.00 yuan and 300000.00 yuan to Li Qiang, a Canadian natural person at the original capital contribution price. Ge Jianli and Huang Honglin respectively issued the statement of consent to transfer and agreed to waive the preemptive right to the other party’s equity.
On July 6, 2006, the Department of foreign trade and economic cooperation of Zhejiang Province issued the reply of the Department of foreign trade and economic cooperation of Zhejiang Province on the merger and acquisition of equity of Zhejiang Jiashan Chengda Pharmaceutical Chemical Co., Ltd. and its change into a Sino foreign joint venture (zwgtzh [2006] No. 293), agreeing to the above equity transfer and change into a Sino foreign joint venture.
On July 11, 2006, Chengda Co., Ltd. obtained the approval certificate of foreign invested enterprises of the people’s Republic of China (s.w.z.f.z. [2006] No. 00680) issued by the people’s Government of Zhejiang Province.
On August 9, 2006, Chengda Co., Ltd. obtained the business license of enterprise legal person with the registration number of Qi He zhe Jia Zong Zi No. 004066 approved and issued by Jiaxing Administration for Industry and commerce. The legal representative of the company is Ge Jianli. The operation period is from August 9, 2006 to August 8, 2019. The enterprise type is Sino foreign joint venture.
On October 25, 2006, Jiaxing Chengzhou United Certified Public Accountants verified the capital contribution of each shareholder during the equity transfer and change of Chengda Co., Ltd. into a foreign-invested enterprise, and issued the capital verification report (Cheng Hui Yan Zi [2006] No. 625) for confirmation. After the completion of the equity transfer, the equity structure of Chengda Co., Ltd. is as follows:
Capital contributed by the contributor
